Table 3.
Parameter | BASAL PB (n = 15) |
BASAL VD (n = 15) |
PB (n = 15) |
VD (n = 15) |
---|---|---|---|---|
Total proteins (g/dL) | 7.1 ± 0.1 | 7.2 ± 0.1 | 7.2 ± 0.1 | 7.2 ± 0.1 |
Uric acid (mg/dL) | 4.8 ± 0.4 | 4.9 ± 0.5 | 4.9 ± 0.3 | 5.3 ± 0.4 |
Creatinine (mg/dL) | 1.3 ± 0.1 | 1.4 ± 0.2 | 1.2 ± 0.0 | 1.3 ± 0.1 |
AST (U/L) | 34.3 ± 3.4 | 30.9 ± 2.2 | 31.3 ± 2.2 | 33.1 ± 2.5 |
ALT (U/L) | 24.8 ± 1.6 | 24.8 ± 3.1 | 24.6 ± 1.3 | 25.6 ± 2.0 |
GGT (U/L) | 18.9 ± 1.7 | 19.6 ± 1.4 | 18.6 ± 1.7 | 19.0 ± 2.5 |
CK (U/L) | 145.9 ± 99.5 | 139.1 ± 93.2 | 158.6 ± 88.0 | 127.2 ± 85.1 * |
LDH (U/L) | 381.5 ± 18.7 | 379.7 ± 20.0 | 373.1 ± 20.5 | 386.2 ± 17.7 |
ALD (U/L) | 7.0 ± 0.5 | 7.3 ± 0.4 | 7.1 ± 0.5 | 7.2 ± 0.7 |
CRP (mg/L) | 2.3 ± 2.0 | 2.3 ± 2.4 | 3.1 ± 2.2 | 2.5 ± 1.9 |
Cortisol (µg/dL) | 18.7 ± 1.2 | 18.8 ± 1.8 | 17.2 ± 1.3 | 19.8 ± 1.3 |
* Indicates significant differences comparing the intervention group VD with respect to the corresponding basal value (Wilcoxon’s paired test). Abbreviations used: ALD, aldolase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP, C-reactive protein; GGT, gamma-glutamyl transferase; LDH, lactate dehydrogenase; PB, placebo group; VD, vitamin D-supplemented group.